Drug Trial Radar · NCT06708156
The Effectiveness and Safety of Two Low-concentration Atropine Sulfate Eye Drops (0.01%/0.02%) for Delaying the Pediatric Myopia Progression
Last checked: Nov 20, 2026Latest source record: Dec 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
606
Planned (sponsor's estimate)
Start
Jun 15, 2024
Primary completion
Dec 31, 2026
Study completion Dec 31, 2027
Sponsor
- Lead sponsor
- Oupushifang Pharmaceutical Technology Co., Ltd.Academic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Seefunge Pharmaceutical Technology Co., Ltd.; AUTEK China Inc.
- First posted
- Nov 27, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 6 years, up to 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The clinical trial aims to test the effectiveness and safety of two low-dose atropine sulfate eye drops for delaying myopia progression in children and adolescents. Primary Objective: evaluate the effectiveness of 0.01% and 0.02% atropine sulfate eye drops for 96 weeks compared to placebo in delaying myopia progression in children and adolescents. Secondary Objective: evaluate the safety of two low-concentration atropine sulfate eye drops (0.01%/0.02%) in delaying myopia progression in children and adolescents. Exploratory Objective: 1. the efficacy and safety of two low-concentration atropine sulfate eye drops (0.01%/0.02%) for 144 weeks. 2. evaluate the rebound effect of two low-concentration atropine sulfate eye drops (0.01%/0.02%) after discontinuation.
Conditions
- Myopia
- Myopia Progression
Interventions
Atropine sulfate eye drops 0.01%Drug
Drug: 0.01% atropine sulfate eye drops Dosage form and strength: 0.01% (0.4 mL: 0.04 mg) eye drops Usage: both eyes, 1 drop in each eye, once a day, every night before sleep, gently press the dacryocyst on both sides for about 1 minute.
Atropine sulfate eye drops 0.02%Drug
Drug: 0.02% atropine sulfate eye drops Dosage form and strength: 0.02% (0.4 mL: 0.08 mg) eye drops Usage: both eyes, 1 drop in each eye, once a day, every night before sleep, gently press the dacryocyst on both sides for about 1 minute.
Placebo eye dropsDrug
Drug: placebo eye drops Dosage form and strength: 0.4 mL eye drops Usage: both eyes, 1 drop in each eye, once a day, every night before sleep, gently press the dacryocyst on both sides for about 1 minute.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Effective change from baseline in equivalent spherical refraction at Week 96 visitTime frame: At the Week 96 visit
Locations
25 sites in 1 country. Site status is shown where the registry gives one.
Beijing Tongren Hospital Affiliated to Capital Medical University
Beijing, China · Recruiting
Peking University Third Hospital
Beijing, China · Recruiting
Chongqing Aier Eye Hospital
Chongqing, China · Recruiting
Shanghai Eye Disease Prevention and Treatment Center (Shanghai Eye Hospital)
Shanghai, China · Recruiting
Tianjin Medical University Eye Hospital
Tianjin, China · Recruiting
Hefei Maternal and Child Health Hospital
Hefei, Anhui, China · Recruiting
The Second Hospital of Anhui Medical University
Hefei, Anhui, China · Recruiting
Xuancheng People's Hospital
Xuancheng, Anhui, China · Recruiting
The Second Hospital of Lanzhou University
Lanzhou, Gansu, China · Recruiting
Liuzhou People's Hospital
Liuzhou, Guangxi, China · Recruiting
The People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, China · Recruiting
The Affiliated Hospital of Guizhou Medical University
Guiyang, Guizhou, China · Recruiting
The First People's Hospital of Zunyi
Zunyi, Guizhou, China · Recruiting
Daqingshi People's Hospital
Daqing, Heilongjiang, China · Recruiting
Kaifeng Central Hospital
Kaifeng, Henan, China · Recruiting
The First Affiliated Hospital of University of South China
Hengyang, Hunan, China · Recruiting
Huai'an First People's Hospital
Huai'an, Jiangsu, China · Recruiting
Affiliated Eye Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China · Recruiting
Weifang Eye Hospital
Weifang, Shandong, China · Recruiting
Heping Hospital Affiliated to Changzhi Medical College
Changzhi, Shanxi, China · Recruiting
Shanxi Eye Hospital
Taiyuan, Shanxi, China · Recruiting
Xianyang Hospital of Yan'an University
Xianyang, Shanxi, China · Recruiting
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.